Advertisement
This call is being webcast by Thomson/CCBN and can be accessed at Baxter'sWeb site at http://www.baxter.com/. The conference call will be recorded byBaxter and is copyrighted material. It cannot be recorded or rebroadcastwithout Baxter's permission.
Advertisement
The webcast is also being distributed through the Thomson StreetEventsNetwork. Individual investors can listen to the call at www.earnings.com,Thomson's individual investor portal, powered by StreetEvents. Institutionalinvestors can access the call via Thomson StreetEvents (www.streetevents.com),a password-protected event management site.
Baxter International Inc. develops, manufactures and markets products thatsave and sustain the lives of people with hemophilia, immune disorders,cancer, infectious diseases, kidney disease, trauma, and other chronic andacute medical conditions. As a global, diversified healthcare company, Baxterapplies a unique combination of expertise in medical devices, pharmaceuticalsand biotechnology to create products that advance patient care worldwide.Contact Information: Investor Relations Contact Mary Kay Ladone, +1-847-948-3371 [email protected] Clare Trachtman, +1-847-948-3085 [email protected]
SOURCE Baxter International Inc.